Particle.news

States Step In on Vaccine Guidance as CDC Chief Considers ACIP’s September Changes

Regional coalitions are issuing joint recommendations to preserve access during the federal review period.

Overview

  • ACIP kept COVID-19 vaccination for everyone 6 months and older under shared clinical decision making with no prescription required, recommended separate MMR and varicella doses before age 4, and left the hepatitis B birth dose unchanged while reaffirming universal prenatal HBV testing.
  • The recommendations require sign‑off by acting CDC director Jim O’Neill before taking formal effect, and clinicians are being told to plan for typical ordering needs with a possible supply pinch as use shifts away from MMRV.
  • Coverage through Vaccines for Children, Medicare, Medicaid, and commercial insurers is expected to continue without new prescription requirements, according to clinical and payer reporting.
  • Experts warn near‑term implementation will be uneven across pharmacy chains, payers, and states, and clinicians are emphasizing counseling for high‑risk groups and during pregnancy.
  • States are moving on their own: West Coast and Northeast blocs have issued broader joint guidance and coordination plans to maintain access, while Florida is advancing a rollback of childhood vaccine requirements, deepening a patchwork of policies.